Pharmaceutical community eyeing FDA guidance on nitrosamines with great interest ...
Nitrosamines are naturally occurring chemical compounds that people are regularly exposed to at low levels.
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies from around the world recently publishing new or revised guidances on nitrosamines.
Generic medicines have benefited millions of Americans and saved trillions of dollars.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
Revised on: January 17, 2023
Persistent and long-lasting shortages of childhood cancer treatments undermine the advancements in science that have helped to increase childhood cancer survival rates to 85 percent.